Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitral valve replacement for lupus valvulitis.

B Rozman, N Radovanović, M Zorc

    Zeitschrift Fur Rheumatologie
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Organization of intensive cardiac care units in Europe: Results of a multinational survey.

    European heart journal. Acute cardiovascular care·2020
    Same author

    Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in slovenian patients with type 2 diabetes mellitus.

    Balkan journal of medical genetics : BJMG·2016
    Same author

    Mast Cells Might Have a Protective Role against the Development of Calcification and Hyalinisation in Severe Aortic Valve Stenosis.

    Folia biologica·2016
    Same author

    Genome-wide in silico screening for microRNA genetic variability in livestock species.

    Animal genetics·2013
    Same author

    Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.

    Phlebology·2012
    Same author

    Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.

    Lupus·2012

    This study reports the longest survival after mitral valve replacement for lupus valvulitis. A 47-year-old patient with lupus valvulitis survived for over four years post-prosthesis implantation.

    Area of Science:

    • Cardiology
    • Rheumatology
    • Medical Case Study

    Background:

    • Lupus valvulitis is a rare cardiac manifestation of systemic lupus erythematosus.
    • Mitral insufficiency secondary to lupus valvulitis necessitates surgical intervention.
    • Prosthetic valve replacement is a treatment option for severe mitral regurgitation.

    Observation:

    • A 47-year-old patient with a 6.5-year history of lupus valvulitis presented with mitral insufficiency.
    • The patient underwent successful mitral valve replacement with a Starr-Edwards prosthesis four years prior to this report.
    • This represents a prolonged survival period for a patient with this condition.

    Findings:

    • The patient achieved the longest reported survival duration after mitral valve replacement for lupus valvulitis.

    Related Experiment Videos

  • The Starr-Edwards prosthesis demonstrated durability and efficacy in this specific clinical context.
  • Successful management of lupus valvulitis-associated cardiac dysfunction is achievable.

    • Implications:

    • This case highlights the potential for long-term survival in patients with lupus valvulitis undergoing valve replacement.
    • It underscores the importance of multidisciplinary management for autoimmune-related cardiac conditions.
    • Further research into long-term outcomes and optimal prosthetic choices for lupus valvulitis patients is warranted.